1. Home
  2. KRG vs CYTK Comparison

KRG vs CYTK Comparison

Compare KRG & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRG
  • CYTK
  • Stock Information
  • Founded
  • KRG 1971
  • CYTK 1997
  • Country
  • KRG United States
  • CYTK United States
  • Employees
  • KRG N/A
  • CYTK 498
  • Industry
  • KRG Real Estate Investment Trusts
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRG Real Estate
  • CYTK Health Care
  • Exchange
  • KRG Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • KRG 5.0B
  • CYTK 4.4B
  • IPO Year
  • KRG 2004
  • CYTK 2004
  • Fundamental
  • Price
  • KRG $23.27
  • CYTK $36.81
  • Analyst Decision
  • KRG Buy
  • CYTK Buy
  • Analyst Count
  • KRG 8
  • CYTK 14
  • Target Price
  • KRG $27.25
  • CYTK $70.92
  • AVG Volume (30 Days)
  • KRG 1.4M
  • CYTK 1.3M
  • Earning Date
  • KRG 07-30-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • KRG 4.68%
  • CYTK N/A
  • EPS Growth
  • KRG N/A
  • CYTK N/A
  • EPS
  • KRG 0.06
  • CYTK N/A
  • Revenue
  • KRG $856,165,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • KRG $3.42
  • CYTK $27.08
  • Revenue Next Year
  • KRG $2.94
  • CYTK $652.09
  • P/E Ratio
  • KRG $371.72
  • CYTK N/A
  • Revenue Growth
  • KRG 3.94
  • CYTK 412.21
  • 52 Week Low
  • KRG $18.52
  • CYTK $29.31
  • 52 Week High
  • KRG $28.24
  • CYTK $61.27
  • Technical
  • Relative Strength Index (RSI)
  • KRG 58.48
  • CYTK 49.15
  • Support Level
  • KRG $22.52
  • CYTK $36.71
  • Resistance Level
  • KRG $23.04
  • CYTK $38.54
  • Average True Range (ATR)
  • KRG 0.38
  • CYTK 1.28
  • MACD
  • KRG 0.03
  • CYTK -0.22
  • Stochastic Oscillator
  • KRG 93.33
  • CYTK 3.25

About KRG Kite Realty Group Trust

Kite Realty Group Trust specializes in owning, operating, acquiring, developing, and redeveloping high-quality open-air shopping centers and mixed-use assets. The company generates the majority of its revenue from contractual rents and reimbursement payments received from tenants.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: